Cancer Research UK Online Project Launch and Networking Session
Around 60,000 patients in the UK are living with a brain tumour. Overall, only 20% of brain tumour patients are alive five years after diagnosis, in part because they present late with large inoperable tumours.
In the UK in 2013 38 percent of brain tumour patients visited their GP five times or more before referral to secondary care for diagnosis by imaging MRI/CT scan and neurosurgical biopsy, because symptoms, such as headache, are so non-specific.
University of Bristol Principal Investigators Dr Kathreena Kurian (Bristol Medical School: Population Health Sciences) and Dr Sabine Hauert (Department of Engineering Mathematics) have been awarded just under £500,000 from Cancer Research UK’s Early Diagnosis Project Grant team to Develop a cheap sensitive blood test for early detection of new and proven biomarkers of glioblastoma using fluorescent carbon dots and nanophotonics which will start in October 2020.
The team includes a number of co-leads: Dr Neciah Dorh (FluoretiQ Limited), Prof Carmen Galan (Chemistry), Prof Richard Martin (Bristol Medical School: Population Health Sciences) and patient/charity lead Dr Helen Bulbeck (Brainstrust).
This research project will explore the use of nanoparticles to fluorescently label very low levels of biomarkers in blood samples and other fluids and thus develop a new, quick and affordable test to detect early stage brain tumours without the need for costly or invasive procedures.
Come and join members of the research team as they explain how the research idea was conceived, developed and turned into a funding application, and gain insight into how an interdisciplinary team comprising clinicians, academics, industrial partners and charity representatives worked together to successfully build a concept into a workable project.
Each speaker will also explain how each piece of the larger whole will contribute to the project as it progresses.
The event, which is now taking place online, will comprise a series of 15-minute talks and there are breaks to allow for more in-depth discussions with speakers and Q&As.
Chair: Kathreena Kurian
|09:45 - 09:50||Welcome: John Iredale PVC (Health), University of Bristol||https://youtu.be/g0UNkgi-pjQ|
|09:50 - 10:05||David Crosby||Head of Prevention and
Early Detection Research,
|10:05 - 10:20||Kathreena Kurian (University of Bristol) and Ping Chen (North Bristol NHS Trust)||Brain Cancer||https://youtu.be/RoGrfkVVtn4|
|10:20 - 10:35||Sabine Hauert (University of Bristol)||Modelling||https://youtu.be/2HeJJJ779j8|
|10:35 - 10:50||Neciah Dorh||FluoretiQ Limited||https://youtu.be/3KCNJFVsVB4|
|10:50 - 11:10||Break / Networking|
|11:10 - 11:25||Carman Galan (University of Bristol)||Nanotechnologies||https://youtu.be/uaivXHQEegs|
|11:25 - 11:40||Richard Martin (University of Bristol)||Cancer epidemiology||https://youtu.be/nCxYveiIpAQ|
|11:40 - 11:55||Julie Stock||CRUK Entrepreneurs||https://youtu.be/cd2G5Kp40kk|
|11:55 - 12:10||Helen Bulbeck||Brainstrust||https://youtu.be/GpUtKtxyERQ|
|12:10 - 12:30||Networking|
Please address any enquiries to Catherine Brown.